Cybin Inc (CYBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYBN | AMGN | VRTX | REGN | BMY |
| Company | Cybin Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.3400 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 0.3470 | 278.02 | 402.48 | 905.91 | 44.47 |
| Low | 0.3370 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 0.3438 | 278.54 | 404.70 | 910.75 | 44.33 |
| Change | -0.0062 | +4.60 | +11.89 | +20.09 | +0.39 |
| % Change | -1.77% | +1.68% | +3.03% | +2.26% | +0.89% |
| Volume | 1,783,215 | 1,008,920 | 562,644 | 229,156 | 8,188,054 |
| 20-Day Average Volume | 3,522,217 | 2,174,169 | 963,737 | 457,821 | 13,784,283 |
| Previous Close | 0.3500 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3758 | 269.63 | 398.82 | 908.99 | 48.21 |
| 20-Day Raw Stochastic | 3.90% | 94.36% | 43.74% | 29.39% | 4.03% |
| 20-Day Relative Strength | 40.19% | 51.85% | 46.47% | 41.52% | 27.80% |
| Weighted Alpha | -32.31 | +13.96 | +14.12 | +16.68 | -36.52 |
| Today's Opinion | 88% Sell | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Previous Opinion | 88% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 8% Buy | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.72% since 04/24/24 | +1.21% since 04/24/24 | -0.07% since 04/24/24 | -0.63% since 04/24/24 | -9.81% since 04/24/24 |
| Low | 0.3370 on 05/01/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.3519 on 04/26/24 | 277.24 on 05/01/24 | 403.88 on 04/25/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -19.41% since 04/01/24 | -2.38% since 04/01/24 | -4.76% since 04/01/24 | -7.07% since 04/01/24 | -16.84% since 04/01/24 |
| Low | 0.3370 on 05/01/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.4699 on 04/03/24 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | -6.10% since 02/01/24 | -14.87% since 02/01/24 | -7.70% since 02/01/24 | -5.95% since 02/01/24 | -9.46% since 02/01/24 |
| Low | 0.2831 on 02/07/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.5224 on 03/13/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -40.14% since 11/01/23 | +5.93% since 11/01/23 | +8.43% since 11/01/23 | +13.84% since 11/01/23 | -14.07% since 11/01/23 |
| Low | 0.2831 on 02/07/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 0.6200 on 11/02/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 143,799 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 410,855 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -35,930,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -22,270,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.43 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 02/14/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 02/13/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |